Suchergebnisse - "Buzzetti, Raffaella"

PubPharm (288)

1

LADA 30th anniversary : A growing form of diabetes with persistent unresolved questions

enthalten in: Diabetes/metabolism research and reviews | 2024

von Lee Jia Jia, I. | Buzzetti, R. | Leslie, R. | +1

2

Immune checkpoint modulators in early clinical development for the treatment of type 1 diabetes

enthalten in: Expert opinion on investigational drugs | 2024

von Maddaloni, E. | Amendolara, R. | Balena, A. | +3

3

IDegLira for the real-world treatment of type 2 diabetes in Italy. Final results from the REX observational study

enthalten in: Diabetes, obesity & metabolism | 2024

von Fadini, G. | Buzzetti, R. | Pitocco, D. | +7

4

Validation in type 2 diabetes of a metabolomic signature of all-cause mortality

enthalten in: Diabetes/metabolism research and reviews | 2024

von Copetti, M. | Baroni, M. | Buzzetti, R. | +12

5

Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care : a comparative effectiveness study on propensity score matched cohorts at low renal risk

enthalten in: The Lancet regional health. Europe | 2024

von Fadini, G. | Longato, E. | Morieri, M. | +69

6

Correction : An updated algorithm for an effective choice of continuous glucose monitoring for people with insulin-treated diabetes

enthalten in: Endocrine | 2024

von Maiorino, M. | Buzzetti, R. | Irace, C. | +5

ErratumFor: Endocrine. 2023 Nov;82(2):215-225. - PMID 37676398

7

MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus

enthalten in: Diabetes & metabolism | 2024

von Mantovani, A. | Morieri, M. | Aldigeri, R. | +16

8

Saxagliptin/dapagliflozin is non-inferior to insulin glargine in terms of β-cell function in subjects with latent autoimmune diabetes in adults : A 12-month, randomized, comparator-controlled pilot study

enthalten in: Diabetes, obesity & metabolism | 2024

von Maddaloni, E. | Naciu, A. | Mignogna, C. | +12

9

Glycated haemoglobin in the first year after diagnosis of type 1 diabetes is an independent risk factor for diabetic retinopathy : The IMDIAB 25 years follow-up study

enthalten in: Diabetes, obesity & metabolism | 2023

von Maddaloni, E. | Carlone, A. | Pitocco, D. | +44

10

Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus

enthalten in: Diabetes & metabolism | 2023

von Csermely, A. | Mantovani, A. | Morieri, M. | +17

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[29]